|
Volumn 24, Issue 5, 1997, Pages 547-555
|
Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CELL ADHESION MOLECULE;
GAMMA INTERFERON;
INDOMETACIN;
MELPHALAN;
PARACETAMOL;
RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;
ADOLESCENT;
ADULT;
ADVANCED CANCER;
AGED;
CANCER COMBINATION CHEMOTHERAPY;
CARDIOTOXICITY;
CHILL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
FEMALE;
FEVER;
HUMAN;
HYPOTENSION;
INFLAMMATION;
INTRAARTERIAL DRUG ADMINISTRATION;
LIMB PERFUSION;
LIMB SALVAGE;
LIVER TOXICITY;
LUNG TOXICITY;
MAJOR CLINICAL STUDY;
MALE;
MAXIMUM ALLOWABLE CONCENTRATION;
NEPHROTOXICITY;
PRIORITY JOURNAL;
REVIEW;
SOFT TISSUE SARCOMA;
SUBCUTANEOUS DRUG ADMINISTRATION;
SURGICAL TECHNIQUE;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHEMOTHERAPY, CANCER, REGIONAL PERFUSION;
DRUG ADMINISTRATION SCHEDULE;
EXTREMITIES;
FEMALE;
HEART-LUNG MACHINE;
HUMANS;
HYPERTHERMIA, INDUCED;
INTERFERON TYPE II;
MALE;
MELPHALAN;
MIDDLE AGED;
RECOMBINANT PROTEINS;
SARCOMA;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0030867737
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (40)
|
References (51)
|